Skip to main content
logo
AmCad BioMed Corporation (TPEX:4188)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
14.60
+1.30 (9.77%)
Aug 26, 2026, 1:20 PM CST

AmCad BioMed Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9259311,4151,4228491,030
Market Cap Growth
-2.34%-34.23%-0.45%67.51%-17.57%0.26%
Enterprise Value
6696391,0501,236617758
Last Close Price
14.6014.7022.3526.1215.6018.93

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
32.3330.5926.6621.7913.7712.00
PB Ratio
1.571.552.132.981.631.78
P/TBV Ratio
2.022.022.824.632.482.62

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
23.3820.9919.7718.9410.018.84

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.010.020.030.020.03
Net Debt / Equity Ratio
-0.56-0.60-0.53-0.57-0.62-0.61
Net Debt / EBITDA Ratio
4.334.656.756.616.2315.19
Net Debt / FCF Ratio
6.937.606.436.519.218.63
Asset Turnover
0.050.050.090.120.110.14
Inventory Turnover
0.630.710.731.001.061.17
Quick Ratio
16.9920.6615.2112.2312.2614.43
Current Ratio
18.4922.6216.6313.3513.1515.33
Return on Equity (ROE)
-11.18%-11.29%-9.26%-8.65%-9.89%-4.58%
Return on Assets (ROA)
-8.61%-8.34%-6.69%-6.33%-6.87%-3.61%
Return on Capital Employed (ROCE)
-14.50%-14.50%-9.70%-11.10%-12.20%-6.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5.69%-5.99%-3.57%-3.19%-6.30%-2.48%
FCF Yield
-5.13%-5.10%-3.85%-2.95%-4.10%-4.01%
Buyback Yield / Dilution
-0.96%-9.75%-8.42%-0.01%--0.09%